BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3347787)

  • 1. [Scintigraphy of the bone marrow for the evaluation of injuries caused by antiblastic agents].
    Ciambellotti E; Cartia GL; Coda C
    Radiol Med; 1988; 75(1-2):78-82. PubMed ID: 3347787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone marrow scintigraphy in multiple myeloma. A comparison with bone scintigraphy and skeletal radiology].
    Feggi LM; Spanedda R; Scutellari PN; Prandini N; Gennari M; Orzincolo C; Scapoli GL; Bagni B
    Radiol Med; 1988 Oct; 76(4):311-5. PubMed ID: 3141987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloid scintigraphy showing red bone marrow extension in patients with prostatic carcinoma.
    Rudberg U; Udén R; Ahlbäck SO
    Acta Radiol; 1992 Mar; 33(2):97-102. PubMed ID: 1562417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Scintigraphy of bone marrow for the evaluation of injuries caused by antiblastic radiotherapy].
    Coda C; Cartia GL; Ciambellotti E
    Minerva Med; 1987 Nov; 78(21):1611-5. PubMed ID: 3683958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone marrow scintigraphy with 99mTc nanocolloid. A complement to bone scintigraphy with 99mTc MDP in oncologic diagnosis].
    Cartia GL; Ciambellotti E; Coda C
    Minerva Med; 1991 Nov; 82(11):715-21. PubMed ID: 1766572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of bone marrow scintigraphy in hematological diseases].
    Ranner G; Fueger GF; Hörmann M
    Rofo; 1987 Mar; 146(3):300-5. PubMed ID: 3031761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99mTc-nanocolloid bone marrow scintigraphy in prostatic cancer.
    Haddock G; Gray HW; McKillop JH; Bessent RG; Kirk D
    Br J Urol; 1989 May; 63(5):497-502. PubMed ID: 2731008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bone-marrow scanning with technetium-99m sulfur colloid in pediatric oncology.
    Siddiqui AR; Oseas RS; Wellman HN; Doerr DR; Baehner RL
    J Nucl Med; 1979 May; 20(5):379-86. PubMed ID: 232146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow scintigraphy in the diagnosis of post-traumatic avascular necrosis of bone.
    Tawn DJ; Watt I
    Br J Radiol; 1989 Sep; 62(741):790-5. PubMed ID: 2790419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal activity following bone marrow scintigraphy with technetium-99m nanocolloid in patients with multiple myeloma.
    Agren B; Måre K; Aspelin P
    Eur J Nucl Med; 1995 Nov; 22(11):1319-22. PubMed ID: 8575484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone marrow scintigraphy using radiocolloids in bone metastases. Sensitivity, specificity, reliability and indications].
    Fritz P; Adolph J; Bubeck B; Georgi P; zum Winkel K
    Rofo; 1986 Jun; 144(6):689-95. PubMed ID: 3012705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RES scintigraphy in polycythemia vera and secondary or relative polycythemia.
    Rudberg U; Skårberg KO
    Acta Radiol; 1993 Mar; 34(2):183-6. PubMed ID: 8452727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow extension and pelvic bone marrow activity in alcoholic liver disease. A RES scintigraphic investigation.
    Rudberg U
    Acta Radiol; 1992 Sep; 33(5):464-7. PubMed ID: 1389658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of In-111 granulocytes and Tc-99m albumin colloid for bone marrow scintigraphy by the use of quantitative SPECT imaging.
    Axelsson B; Kalin B; Von Krusenstierna S; Jacobsson H
    Clin Nucl Med; 1990 Jul; 15(7):473-9. PubMed ID: 2116948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone and bone marrow scintigraphy in the diagnosis of neoplastic involvement of the skeletal system. A comparative analysis.
    Sacchi S; Marietta M; Rinaldi G; Pantusa M; Romani F; Zaniol P; Torelli U
    J Nucl Med Allied Sci; 1987; 31(3):255-60. PubMed ID: 3694273
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow scintigraphy in small cell carcinoma of the lung.
    Li DJ; Maughan TS; Miles KA; Wraight EP
    Nucl Med Commun; 1994 Jan; 15(1):29-33. PubMed ID: 8152690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial (99m)Tc-macroaggregated albumin administration in patients with bone and soft-tissue tumors.
    Taki J; Sumiya H; Higuchi T; Tsuchiya H; Takazawa K; Tomita K; Tonami N
    J Nucl Med; 2002 Nov; 43(11):1452-6. PubMed ID: 12411547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow imaging: a comparison study using a 99Tcm-sulphur colloid versus a new 99Tcm-microaggregated albumin.
    Blend MJ; Pavel DG
    Nucl Med Commun; 1986 Oct; 7(10):787-9. PubMed ID: 3808497
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases].
    Hotze A; Löw A; Mahlstedt J; Wolf F
    Rofo; 1984 Jun; 140(6):717-23. PubMed ID: 6234628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new formulation of Tc-99m minimicroaggregated albumin for marrow imaging: comparison with other colloids, In-111 and Fe-59.
    McAfee JG; Subramanian G; Aburano T; Thomas FD; Fernandes P; Gagne G; Lyons B; Zapf-Longo C
    J Nucl Med; 1982 Jan; 23(1):21-8. PubMed ID: 6459431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.